---
layout: minimal-medicine
title: Anagrelide
---

# Anagrelide
### Generic Name
Anagrelide

### Usage
Anagrelide is a medication primarily used to treat thrombocythemia, a condition characterized by an abnormally high platelet count in the blood.  This high platelet count is often secondary to myeloproliferative neoplasms (MPNs), a group of blood cancers affecting bone marrow.  By reducing the elevated platelet count, anagrelide helps lower the risk of serious complications like thrombosis (blood clots) and thrombohemorrhagic events (bleeding and clotting simultaneously).  It also aims to alleviate symptoms associated with high platelet counts.  Anagrelide is not a cure for MPNs but manages a key symptom.

### Dosage

**Adults:**  Anagrelide is administered orally. The starting dose is typically 0.5 mg four times daily (QID) or 1 mg twice daily (BID) for at least one week. The maintenance dose is adjusted individually, usually ranging from 0.5 mg to 1 mg two to four times daily.  The maximum single dose is 2.5 mg, and the maximum daily dose is 10 mg. Dose increases should not exceed 0.5 mg per day in any single week. The goal is to reduce and maintain the platelet count below 600,000/mm³, ideally between 150,000/mm³ and 400,000/mm³.

**Children (≥6 years):**  For essential thrombocythemia and secondary thrombocythemia associated with myeloproliferative disorders, the initial dose is typically 0.5 mg once or twice daily. The dose is then titrated upwards at weekly intervals in 0.5 mg increments until the platelet count begins to decrease.  The usual maintenance dose ranges from 1 to 2.5 mg per day, with a maximum daily dose of 10 mg.  Again, increases should not exceed 0.5 mg/day per week.

**Dosage Adjustments:**  Dose adjustments are necessary for individuals with hepatic (liver) impairment. Those with mild impairment may not need dose adjustments but should be carefully monitored.  Moderate impairment may require a lower initial dose (0.5 mg once daily), with careful titration.  Anagrelide is generally avoided in patients with severe hepatic impairment.  Renal (kidney) impairment generally does not require dose adjustments, according to current manufacturer's labeling, though it's crucial to monitor renal function.

### Side Effects

**Common Side Effects (occurring in >10% of patients):**

* Headache
* Dizziness
* Pain
* Palpitations
* Edema (swelling)
* Diarrhea
* Nausea
* Abdominal pain
* Weakness
* Dyspnea (shortness of breath)

**Less Common but Serious Side Effects:**  Anagrelide can cause more serious side effects, though less frequently. These include cardiovascular events (arrhythmias, heart failure), pulmonary complications (pulmonary hypertension, lung fibrosis),  hematologic issues (anemia, bleeding), and hepatic problems (liver enzyme elevations).  These are not exhaustive.

**Important Note:** If any adverse effects occur, consult a healthcare provider immediately.


### How it Works

Anagrelide's precise mechanism of action isn't fully understood, but it primarily affects platelet production. It inhibits an enzyme called cyclic nucleotide phosphodiesterase and also interferes with the release of arachidonic acid, impacting platelet formation in the bone marrow.  This leads to a dose-dependent reduction in the number of megakaryocytes (cells that produce platelets), thus lowering the platelet count.


### Precautions

* **Contraindications:** Anagrelide is contraindicated in patients with a known hypersensitivity to anagrelide or any of its components.
* **Drug Interactions:**  Anagrelide can interact with other medications, including anticoagulants (blood thinners), antiplatelet drugs, and some antifungals and antibiotics.  These interactions may increase the risk of bleeding or alter anagrelide's effectiveness. Always inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **Pregnancy and Breastfeeding:** Anagrelide is categorized as a pregnancy category C drug, meaning its effects on a developing fetus are unknown.  Other medications are generally preferred during pregnancy.  It's also not recommended to breastfeed while taking anagrelide.
* **Cardiovascular Disease:**  Anagrelide should be used cautiously in patients with pre-existing cardiovascular disease due to the potential for cardiac side effects.
* **Renal and Hepatic Impairment:** Use with caution in patients with mild to moderate renal or hepatic impairment; it's usually avoided in patients with severe impairment.


### FAQs

* **Q: Can I take anagrelide with food?** A: Anagrelide can be taken with or without food.
* **Q: How long does it take to see results?** A: The reduction in platelet count usually starts within the first few weeks of treatment, but the optimal dose and response time vary between individuals.
* **Q: How should I store anagrelide?** A: Store anagrelide at room temperature, away from moisture and direct sunlight.
* **Q: Can I stop taking anagrelide abruptly?** A: No.  Always consult your doctor before stopping anagrelide to avoid potential complications.
* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it is almost time for your next dose. Do not take a double dose.
* **Q: Is anagrelide a cure for myeloproliferative neoplasms?** A: No. Anagrelide manages the high platelet count (thrombocythemia), a symptom of MPNs, but it does not cure the underlying disease.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for diagnosis, treatment, and management of medical conditions.  The specific dosage and precautions may vary based on individual patient needs and health status.
